Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Recognizing warning signs of poor investments can help you avoid costly mistakes. Stay proactive in your financial decisions.
13,809 articlesVertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
SK Hynix closed the largest foreign U.S. listing on record, raising $26.5 billion. Analysts question whether the 2026...
A quiet dividend king in the utility space could be the sleeper winner you’ve been waiting for. This article explains...
The space-tech IPO has hit a snag, with shares slipping below the initial price. This guide breaks down what the drop...
Sam Altman is driving OpenAI toward a trillion-dollar target, while SoftBank faces a substantial loan due in 2027. Th...
As U.S.–Iran tensions flare, energy prices surge and corporate boards adjust risk, liquidity and strategy in a newly ...
Public chatter around a high-profile settlement can echo into your finances. This article breaks down the money moves...
Lockheed Martin reports a record backlog near $194 billion, underscoring long-term demand for flagship programs and a...
Thinking about turning a solid investment into a multi-bagger? This guide outlines five stock ideas with the potentia...
Jeanette Cutler steps in as Chief Marketing Officer at Baird & Warner, bringing global brand leadership from Beam Sun...
Palantir trades sales. Here's a clear-eyed view of why the market pays up for this AI-driven data platform, plus acti...
Analysts publish an eyebrow-raising spacex’s $800 price target, implying a potential trillion-dollar leap in value an...